Neurent Medical inks $25m Series B

Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing.

Neurent Medical, a developer of treatments for chronic inflammatory sino-nasal diseases, has secured $25 million in Series B financing. The investors included LSP and Atlantic Bridge.

Source: Press Release